Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3697070016 | Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection ampule | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3697071017 | Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3697072012 | Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3697073019 | Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection ampoule | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has unit of presentation | Ampule (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has manufactured dose form | Solution for injection | false | Inferred relationship | Some | ||
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Is a | Product containing neostigmine in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has presentation strength denominator unit (attribute) | mL | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has presentation strength denominator unit (attribute) | mL | false | Inferred relationship | Some | 2 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Is a | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has presentation strength denominator value | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has concentration strength denominator value | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Count of base of active ingredient | 2 (qualifier value) | false | Inferred relationship | Some | ||
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has concentration strength denominator value | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 2 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has presentation strength denominator value | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has basis of strength substance (attribute) | Neostigmine methylsulfate | false | Inferred relationship | Some | 2 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has concentration strength numerator value (attribute) | 500 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has precise active ingredient | Glycopyrronium bromide | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has presentation strength numerator value (attribute) | 500 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has presentation strength numerator value (attribute) | 2.5 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has concentration strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has basis of strength substance (attribute) | Glycopyrronium bromide | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has concentration strength numerator value (attribute) | 2.5 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has presentation strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Has precise active ingredient | Neostigmine methylsulfate | false | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR